User Guide for High Quality Olaparib CAS 763113-22-0 With Best Price

Table of Contents

• Basic Information and Parameters
• Uses of the Product
• How to Use the Product
• Usage Case Studies
• Contact Information

Basic Information and Parameters

Our product, High Quality Olaparib CAS 763113 - 22 - 0, is a pharmaceutical - grade compound. Olaparib is a poly (ADP - ribose) polymerase (PARP) inhibitor. The CAS number 763113 - 22 - 0 uniquely identifies this compound, allowing for easy reference in scientific research and drug development.

It is presented in a high - quality form, which means it has been produced under strict quality control measures. The purity of our Olaparib is extremely high, ensuring reliable results in various applications. The product is usually available in powder form, which is convenient for storage and further processing.

Uses of the Product

Olaparib is mainly used in oncology research and treatment. As a PARP inhibitor, it plays a crucial role in targeting cancer cells with defects in DNA repair pathways, such as those with BRCA1 or BRCA2 mutations. By inhibiting PARP enzymes, Olaparib can prevent the repair of single - strand DNA breaks in cancer cells. This leads to the accumulation of DNA damage and ultimately causes cancer cell death through apoptosis or mitotic catastrophe.

In addition to its direct anti - cancer effects, Olaparib is also used in pre - clinical and clinical research to understand the mechanisms of DNA repair and the development of resistance in cancer cells. It has potential applications in combination therapies with other anti - cancer drugs to enhance treatment efficacy.

How to Use the Product

When using Olaparib, it is essential to follow strict laboratory or clinical procedures. In a laboratory setting, researchers should first dissolve the powder in an appropriate solvent, such as dimethyl sulfoxide (DMSO). The concentration of the solution should be carefully calculated according to the experimental requirements.

In a clinical context, Olaparib is usually administered orally. The dosage and treatment schedule are determined by a medical professional based on the patient's condition, including the type and stage of cancer, as well as the patient's overall health. It is important to take the medication at the prescribed time and with a full glass of water to ensure proper absorption.

Usage Case Studies

Case 1: A 50 - year - old female patient with advanced ovarian cancer and a BRCA2 mutation was treated with Olaparib. Before the treatment, the patient had undergone multiple rounds of chemotherapy with limited success. After starting Olaparib treatment, her cancer symptoms gradually improved. The tumor size decreased significantly, as shown by regular imaging tests. Her quality of life also improved, with reduced pain and increased energy levels. She continued the treatment for several months and achieved a stable disease state.

Case 2: In a pre - clinical study, a research team used Olaparib in combination with a new anti - cancer drug on a mouse model of breast cancer. The results showed that the combination treatment was more effective than either drug alone. The tumors in the mice treated with the combination therapy shrank more rapidly, and the survival rate of the mice was significantly higher compared to the control groups.

Contact Information

If you have any questions about our High Quality Olaparib CAS 763113 - 22 - 0, please feel free to contact us. Our email address is info@vivalr.com, and our phone number is (86) 15866781826. We are committed to providing you with professional support and high - quality products.